WO2026003582 - LIPIDS AND LIPID NANOPARTICLES
National phase entry is expected:
Publication Number
WO/2026/003582
Publication Date
02.01.2026
International Application No.
PCT/IB2025/000348
International Filing Date
27.06.2025
Title **
[English]
LIPIDS AND LIPID NANOPARTICLES
[French]
LIPIDES ET NANOPARTICULES LIPIDIQUES
Applicants **
AXELYF EHF.
Inventors
CORNEBISE, Mark
BENENATO, Kerry, E.
ALMARSSON, Örn
XIA, Yan
Priority Data
63/664,806
27.06.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 6788 | |
| EPO | Filing, Examination, Granting | 97923 | |
| Japan | Filing, Examination, Granting | 4793 | |
| South Korea | Filing, Examination, Granting | 7328 | |
| USA | Filing, Examination, Granting | 24190 |
Total:
141,022
Contact Us
Abstract[English]
The disclosure provides for lipids that may be formulated in a delivery vehicle to facilitate the encapsulation of a wide range of single or multiple payloads including therapeutic, theragnostic, preventive, prophylactic, pre-emptive, and diagnostic agents, such as, without limitation, nucleic acids (e.g., RNA or DNA), proteins, peptides, and small molecule active pharmaceutical ingredients (APIs). Methods of delivering and/or producing a polypeptide of interest in a cell are also provided.[French]
L'invention concerne des lipides qui peuvent être formulés dans un véhicule d'administration pour permettre l'encapsulation d'une large gamme de charges utiles simples ou multiples comprenant des agents thérapeutiques, théragnostiques, préventifs, prophylactiques, préemptifs et diagnostiques, tels que, sans limitation, des acides nucléiques (par exemple, ARN ou ADN), des protéines, des peptides et des ingrédients pharmaceutiques actifs (API) à petites molécules. L'invention concerne également des procédés d'administration et/ou de production d'un polypeptide d'intérêt dans une cellule.